Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Abbott Diabetes Care
Study ID
NCT06668935
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes Mellitus

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists — DEVICE
    All subjects will then begin use of their prescribed GLP-1 or combination GIP/GLP-1 medication in accordance with the HCP's instructions. Subjects will be titrated to their maximum tolerable dose per the medication's approved titration schedule and according to their HCP's standard of care between Visits 2 and 3.

Study Details

This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.

Key Dates

Start date
Oct 24, 2024
Status verified
Oct 2024
Primary completion
Oct 31, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
800 participants (estimated)

Arms

  • Arm: Randomization to FSL 3 or Standard of Care
    Subjects with type 2 diabetes who are newly beginning GLP-1 or dual GLP-1/GIP drug therapy will be randomized to use either the FSL3 or their existing Standard of Care (SOC) to manage their diabetes.

Primary Outcome Measure

To assess the length of time subjects in each group remain on a GLP-1 or GLP-1/GIP combination drug [ Time Frame: 210 days ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
East Coast Institute for Research, LLCJacksonvilleFlorida32216
Rebecca Goldfaden, Pharm D
[email protected]
904-854-1354
Wasim Deeb, MD (PRINCIPAL_INVESTIGATOR)
Excellence Medical and ResearchMiami GardensFlorida33169
Alexander Martinez, OD
[email protected]
786-320-5229
Miguel Trujillo, DNP (PRINCIPAL_INVESTIGATOR)

Find similar trials in Jacksonville, FL

By research site
East Coast Institute for Research, LLC· Jacksonville, FLExcellence Medical and Research· Miami Gardens, FL

Related Studies